Moberg Pharma AB (publ)

Moberg Pharma AB (publ) is a Aktiebolag in Bromma, Sweden with one subsidiary reporting it as a consolidating parent.

The LEI has been on record for 10 years, since 1 Mar 2016. That is about 4 years earlier than the median LEI in Sweden, which dates from 2020 — an early adopter by local standards.

The next annual re-validation is due 29 Jun 2027, 234 days from now.

The record has not changed since we began archiving it on 6 Jul 2026. Any future change to name, status, address, ownership or renewal date will be captured here, because GLEIF publishes only the current state and superseded values are otherwise lost.

The entity is registered with Companies Register under registry number 556697-7426, and the LEI itself is issued and maintained by Bloomberg Finance L.P., one of the Local Operating Units accredited by GLEIF.

Beyond the LEI, 4 ISINs are mapped to this entity in the GLEIF cross-reference files.

No direct accounting-consolidating parent is reported, because no parent prepares consolidated accounts that include it. GLEIF requires this to be stated explicitly rather than left blank, so the absence is itself a data point.

No ultimate accounting-consolidating parent is reported, because no parent prepares consolidated accounts that include it. GLEIF requires this to be stated explicitly rather than left blank, so the absence is itself a data point.

The LEI registration is issued, and the entity status (active) records whether the legal entity itself still exists. The two are independent: an LEI can lapse while the company trades on, and it can stay issued after the company has been dissolved.